We are an early-stage startup founded by a pharmaceutical professional dedicated to improving the drug development process, especially clinical trials.
Our mission is to leverage AI and machine learning to address critical challenges in drug development—in a meaningful way. We don't aim to replace researchers and specialists, but to empower them with tools that unlock their full potential, enabling new insights across a broader scope.
Our goal is to make safe, effective, and affordable treatments more accessible for people worldwide by accelerating the drug development process, enhancing safety, improving efficacy, and reducing the costs associated with drug development.
We strive to pave the way for a new era of modern drug development.
We are committed to upholding the highest ethical standards and ensuring regulatory compliance in healthcare and technology development, safeguarding trust and integrity at our core.
Join Us in Shaping the Future
We are open to strategic partnerships and collaborations with pharmaceutical companies, CROs, and academic institutions. If you'd like to learn more about our vision and progress, please feel free to contact us directly to request a pitch deck or discuss a potential prototype demonstration.
Company Details
- Employees
- 1
- Founded
- 2025
- Address
- Critical Challenges In Drug Development—in A Meaningful Way. We Don't Aim To Replace Researchers And Specialists
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Clonosapiens Questions
Clonosapiens's LinkedIn profile is https://www.linkedin.com/company/clonosapiens
Clonosapiens has
1 employees.
View email and phone details for 1
employees at Clonosapiens.
Clonosapiens's industry is
Research Services
Clonosapiens's top competitors are
Proteina Limited,
Mb Kazanas Ant Ratų,
Techface,
Enable Healthcare,
Xpanmed,
Erbiosys,
Optimal Pims Pharmatech Solution Inc.,
Cellter,
Alpine-Bio,
Lnga Consulting.
Clonosapiens's categories are Research Services
Clonosapiens's founding year is 2025
